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The role of myosin light chain kinase (MLCK) in inducing podosomes was examined by confocal and
electron microscopy. Removal of myosin from the actin core of podosomes using blebbistatin, a myosin
inhibitor, resulted in the formation of smaller podosomes. Downregulation of MLCK by the transfection
of MLCK small interfering RNA (siRNA) led to the failure of podosome formation. However, ML-7, an
inhibitor of the kinase activity of MLCK, failed to inhibit podosome formation. Based on our previous
report (Thatcher et al. J.Pharm.Sci. 116 116e127, 2011), we outlined the important role of the actin-
binding activity of MLCK in producing smaller podosomes.
© 2015 Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological Society. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).A podosome is a membrane protrusion, the intracellular struc-
ture of which has actin ﬁlaments at its core (1e3). A7r5 smooth
muscle cells, (a rat thoracic aorta cell line), form few, if any,
podosomes in culture, but podosomes were induced on their sur-
face when phorbol 12, 13 dibutyrate (PDBu) was added to the cul-
ture medium. PDBu has also been shown to cause contraction of
cultured cells (4), indicating the interaction between the actin core
and the myosin (myosin II isoform). However, to the best of our
knowledge, few publications have reported on the role of myosin in
podosome formation (5, for review). In this study, we removed
myosin from podosomes with blebbistatin, an inhibitor of myosin
ATPase activity, so as to examine the podosome ultrastructure was
modiﬁed based on our own previous report (6).
Myosin light chain kinase (MLCK) is a serine/threonine kinase
that regulates the contraction and motility of vascular smooth
muscle cells (VSMC) (7, 8). The domain structure (7, 8) of MLCK
shows that the localization of the kinase domain and the actin-
binding domain are distinct from each other. We obtained an).
rmacological Society.
r B.V. on behalf of Japanese Pharmactin-binding fragment of MLCK as a recombinant protein to
demonstrate that actin-binding activity is independent of the ki-
nase activity (9, 10). The interaction of MLCK with the actin-core
was demonstrated by the ﬂuorescence resonance energy transfer
(FRET) experiment (Fig. 5 Ref. 4). In this article on the basis of
electron microscopic observation, we described how the actin-
binding domain plays an important role in the protrusion of
podosomes in A7r5 cells.
First, in a pharmacological approach, we attempted to add the
speciﬁc inhibitor of myosin ATPase activity or that of kinase activity
of MLCK to the culture medium of A7r5 cells, followed by obser-
vation with ﬂuorescent confocal microscopy. Then, PDBu (ﬁnal
concentration, 106 M) was added to the culture medium of A7r5
cells, a typical VSMC. After incubation for speciﬁed periods, cells
that formed podosomes were counted in culture plates, as
described in Fig. 1. The numbers of A7r5 cells with podosomes
increased as time elapsed. VSMCs with podosomes were maximal
within 30 min, with approximately 90% of cells developing podo-
somes (Fig. 1A, continuous line), conﬁrming our previous obser-
vation (4). When A7r5 cells were transfected with MLCK small
interfering RNA (siRNA), the sequence of which is described in the
legend to Fig. 1, the expression of both long (220 kDa) and short
(130 kDa) MLCK was effectively down-regulated, as shown by theacological Society. This is an open access article under the CC BY-NC-ND license
Fig. 1. MLCK plays an essential role in inducing podosomes in A7r5 smooth muscle cells, as shown by immunoﬂuorescent microscopy. The procedures of cell culture, MLCK
downregulation, immunoblot, and double staining by anti-actin and anti-MLCK antibodies have been described in Wang et al (14). In brief, A7r5 cells, a VSMC line derived from
embryonic rat aorta (purchased from the American Type Culture Collection), were cultured in Dulbecco's modiﬁed Eagle' s medium (DMEM, Invitrogen) containing 10% fetal bovine
serum, 100 U/mL penicillin, and 100 ug/mL streptomycin using a humidiﬁed incubator (37 C, 5% CO2 þ 95% air). Small interfering RNA (siRNA) targeting both long (220 kDa) and
short (130 kDa) isoforms of MLCK was determined by the Invitrogen BLOCK-iT RNAi Designer online program (http://maidelingner.invitrogen.com/mailexpress/-) according to the
gene sequence of rat smooth muscle MLCK (accession number NM057209). The MLCK siRNA targeting sequence; was 50-AAGTATCTGATGTATATGACA-30 . Scrambled siRNA of a
nonspeciﬁc nucleotide sequence was designed by an online designer (http://www.sirnawizard.com/scrambled.php) and was 50-GGTAATATCGTATAGAACTTA-30 . The transfection of
siRNA into the cell was performed using the nucleofector electroporation system (Amaxa). A. Time course of induction of podosomes in A7r5 cells. Cells transfected with vehicle
(continuous line), scrambled siRNA (dotted line), or MLCK siRNA (broken line) were stimulated by the addition of 10e6 M PDBu to the dishes for 2 min, 10 min, 30 min, 60 min, and
90 min. These stimulated cells were ﬁxed using 1.5% paraformaldehyde in phosphate buffered saline (PBS, pH 7.3); their membranes were then permeabilized with PBS containing
0.5% Triton X-100 and 10% sucrose, followed by double immunostaining with antibodies against MLCK and a-actin, as described below (C). Cells with podosomes were identiﬁed to
contain 10 or more bright dots and/or their assemblies, i.e., rosettes, according to Spinardi and Marchis (2). More than 50 cells with and without podosomes were counted under
each time point. B. Immunoblots. Vehicle cells or transfected cells were lysed with lysis buffer containing 50 mM Tris/HCl (pH 7.5), 150 mM NaCl, 1% Nonidet P-40, 0.05% sodium
deoxycholate, and 0.1% SDS. The lysates were subjected to sodium dodecyl sulfate (SDS)- polyacrylamide gel electrophoresis (PAGE) and transferred to a polyvinylidene diﬂuoride
membrane. The membrane was then incubated with a monoclonal antibody speciﬁc for MLCK (clone K36; SigmaeAldrich). The loading control was monitored by a monoclonal
antibody speciﬁc for b-actin (clone AC-15; SigmaeAldrich). The blots were visualized using a secondary antibody conjugated to the Immobilon Western chemiluminescent
H. Tanaka et al. / Journal of Pharmacological Sciences 128 (2015) 78e82 79
H. Tanaka et al. / Journal of Pharmacological Sciences 128 (2015) 78e8280immunoblot (Fig. 1B). On stimulation with 106 M PDBu, cells with
podosomes were reduced to <10% (Fig. 1A, broken line). As a con-
trol for downregulation using siRNA, we designed scrambled siRNA,
as described in the legend to Fig. 1. Despite use of transfection, the
expression of neither MLCK isoforms was affected (Fig. 1B, immu-
noblot), and the number of cells with podosomes was not reduced
(Fig. 1A, dotted line). These transfection experiments (Fig. 1A, B)
were consistent with our previous report using another cell line
(Fig. 7 in Ref. 4).
Images obtained by scanning electron microscopy (SEM) are
shown in Fig. 2AeF. The surfaces of A7r5 cells were smooth in the
absence of PDBu (Fig. 2A), and a small number of protrusions, if any,
were found when examined at higher magniﬁcation (Fig. 2D).
When cells were stimulated with 10e6 M PDBu, the cellular surface
produced a number of podosomes toward the culture medium
(Fig. 2E). Higher magniﬁcation showed that they comprised legs
connecting ball-like feet to the surface of the A7r5 cells (Fig. 2B, E).
Images obtained by transmission electron microscopy (TEM) of the
vehicle and PDBu-stimulated cells are shown in Fig. 2G and H,
respectively. As shown in Fig. 2G, TEM of vehicle cells conﬁrmed, i)
that the tracks comprised bundled actin ﬁlaments (Fig. 2G, double
black arrowheads), ii) that electron-dense myosin heads were
clustered (Fig. 2G, white arrows), and iii) that the dense materials
were penetrated by the bundles of actin ﬁlaments (Fig. 2G, black
arrowheads). Features i)eiii) are often found in relaxed smooth
muscle tissue (11, Fig. 6 in Ref. 6). On stimulation with PDBu
(Fig. 2H), the tracks of actin ﬁlaments were disrupted, and most of
them were capped by the electron-dense ball (Fig. 2H, black ar-
rowheads), impenetrable to actin ﬁlaments. It would be intriguing
to see whether or not the component of the electron-dense balls
(Fig. 2G, black arrowheads) of vehicle cells are identical to those of
the electron-dense foot (Fig. 2H, black arrowheads) of PDBu-
stimulated cells.
Blebbistatin is a known inhibitor of myosin ATPase activity (12).
We added 10e6 M PDBu to the cultures of A7r5 cells in the presence
of blebbistatin. As shown by immunoﬂuorescence micrographs
(Fig. 1, 9e11), PDBu induced podosomes. Quantitative analysis of
A7r5 cells with podosomes (circle graphs of Fig. 1C) indicated that
the majority of A7r5 cells produced podosomes irrespective of the
presence or absence of blebbistatin when we compared Fig. 1C, 8,
with Fig. 1C, 12. Because it is not possible to accurately measure the
dimensions of the feet and legs of podosomes with immunoﬂuo-
rescence microscopy, we analyzed PDBu-stimulated A7r5 cells in
the presence of blebbistatinwith electronmicroscopy. SEM showed
that PDBu induced smaller podosomes in the presence of blebbis-
tatin (Fig. 2F) than in its absence (Fig. 2E), indicating the induction
of smaller feet and shorter legs. TEM (Fig. 2H, I) allowed us to
quantify leg length (nm) and foot size (nm2). Fig. 2J and K shows
histograms of leg length and foot size with mean values indicated
by the arrows in abscissae (black arrows indicating the presence
and gray arrows indicating the absence of blebbistatin). Both leg
length and foot size were reduced in the presence of blebbistatin,
an observation in accordance with SEM micrographs (compare
Fig. 2E with Fig. 2F). In addition, we noticed that actin ﬁlamentshorseradish peroxidase (HRP) substrate (Millipore). C. Immunoﬂuorescent microscopic ima
105 M ML-7 (þML-7) and then stimulated with 10e6 M PDBu (þPDBu) for 30 min. They
antibodies. Primary antibodies were monoclonal anti-a-actin (clone 1A4, SigmaeAldrich) a
ﬂuorescein isothiocyanate (FITC)-conjugated secondary antibody (Jackson Immuno Researc
secondary antibody to recognize anti-MLCK (Sigma Addrich, Red photos). Cells were obs
centage of cells with podosomes after stimulation with 10e6 M PDBu for 30 min (in dark bl
transfection, 17e24 transfected with scrambled siRNA, and 25e32 transfected with MLCK si
polyclonal antibody (H-195) against MLCK (Santa Cruz) was used in this communication in c
against MLCK was employed. We used H-195 for the immunoﬂuorescence microscopy to det
cells, we could not detect any differences between the two antibodies, conﬁrming the validcomprised the actin-core of podosome legs in PDBu-stimulated
cells. In the absence of blebbistatin (Fig. 2H), arrays of round
electron-dense materials of approximately 18 nm in diameter
(white arrows) were identiﬁed as myosin heads to the immuno
electron micrograph in Fig. 6F in Ref. (6). However, in the presence
of blebbistatin, myosin heads as shown by the electron-dense
materials were not associated with the actin core of podosomes
comprising actin ﬁlaments (Fig. 2I, black arrowheads). Instead,
myosin-heads assembled in the areas remote from the legs of
podosomes (Fig. 2H, white arrows). As described above, blebbis-
tatin was effective at 106 M, a concentration lower than those
inhibiting ATPase activity of smooth muscle myosin II (12) and the
contraction of smooth muscle (6). It is unclear which isoform of
myosin II is expressed in A7r5. Thus, additional studies are clearly
required to study isoforms expressed in A7r5 cells.
The observation above regarding the role of myosin in podo-
somes suggests thatmyosin is not essential in podosome formation.
We examined the role of MLCK in podosome formation. As
described in the initial part of this communication (Fig. 1A), stim-
ulation with 106 M PDBu leads to the development of podosomes.
Immunoﬂuorescent images stained by anti-actin and anti-MLCK
antibodies are shown in Fig. 1, as labeled by scrambled siRNA and
MLCK siRNA. Cells treated with scrambled siRNA (Fig. 1C, 17e24)
developed podosomes as well as did PDBu-stimulated vehicle cells
without siRNA treatment (Fig. 1C, 1e08, Fig. 1C, 17e24). However,
cells lacking MLCK expression failed to produce podosomes in the
presence of 106 M PDBu (compare Fig. 1C, 21e24, with Fig. 1C,
29e32). Thus, we concluded that MLCK has an essential role in
podosome formation. To elucidate the role of kinase activity of
MLCK in podosome formation, A7r5 cells were treated with ML-7,
an inhibitor of kinase activity of MLCK, affecting phosphorylation
of myosin light chains (13). Unexpectedly, PDBu-treated cells
developed podosomes with 10e5 M ML-7, similar to control cells
(compare Fig. 1C, 05e08, with Fig. 1C, 13e16).
This unexpected result indicates that the phosphorylation of the
myosin light chains by MLCK is not an essential requirement for
A7r5 to produce podosomes on stimulation with PDBu. We were
interested in the role of the actin-binding activity of MLCK, because
we previously reported the functional interaction between MLCK
and the actin-core of the podosome (Table 1 and Fig. 5 of Ref. 4 by
the FRET analysis). In this communication, we performed immu-
noelectron microscopy using the antibody against MLCK (Fig. 3).
When A7r5 cells were stimulated with 10e6 M PDBu, MLCK labels
detected by 6-nm gold particles were located both on the legs and
the feet; 27.5% per total gold particles in Fig. 3A (white arrows)
were on the legs (black arrows) and feet (black arrowheads) of
podosomes. We noticed that the particles on podosomes were
associated with the myosin-heads arrayed on the actin ﬁlaments
(Fig. 3A).
It remained unclear whether MLCK binds to the actin ﬁlaments
of podosomes through myosin. To answer this question, we per-
formed immunoelectron microscopy on podosomes in which
myosin had been removed from the actin ﬁlaments by blebbistatin
treatment. As shown in Fig. 3B, the percentage of gold particlesges. Cells were cultured in the vehicle medium, 10e6 M blebbistatin (þBlebbistatin) or
were ﬁxed, followed by permeabilization and incubation with primary and secondary
nd polyclonal anti-MLCK antibody (H-195 Santa Cruz). The staining was visualized by
h, Green photos) that recognized anti-a-actin, or was visualized by RED-X-conjugated
erved with a MRC-1024 confocal microscope (Bio-Rad).Circle graphs denote the per-
ue). Podosome-positive cells were identiﬁed as described in A: 01e16 control without
RNA. More than 100 cells were counted for each condition. Scale bars: 2 mm. Note that
ontrast to that used in a previous report (Fig. 7 Ref. 4), where monoclonal K36 antibody
ect podosomes, in judging the effect of pharmacological agents. In the image of vehicle
ity of using H-195.
Fig. 2. PDBu-induced podosomes characterized by electron microscopy (EM). A7r5 cells were stimulated with 106 M PDBu for 30 min and ﬁxed with 1.5% paraformaldehyde in
0.1 M cacodylate buffer for 10 min at 4 C, followed by treatment with 0.5% Triton X-100 in 10% sucrose in the same buffer for 10 min at 4 C. After removing Triton X-100 and
sucrose, cells were postﬁxed with 1% OsO4 and 0.1% tannic acid in the same buffer, followed by dehydration in a series of increasing concentrations of ethanol and t-butyl alcohol.
Finally, the cellular surface was coated with platinum (Pt) at 10-nm thickness using Hitachi Pt coater and observed with a Hitachi 4300 (Hitachi High-Technology Corp.) scanning
electron microscope (SEM). For transmission EM (TEM) observation, 10-nm sections were cut out at approximately 1 mm height parallel from the cell surface, and the sections were
observed with a Hitachi-H7650 (Hitachi High-Technology Corp.) A, B, and C are SEM images at low magniﬁcation (scale bars, 1 mm). The areas surrounded by the white line were
expanded in D, E, and F (scale bars, 100 nm). A, D, and G, vehicle cells; B, E, and H, 106 M PDBu-stimulated cells in the absence of 106 M blebbistatin. C, F, and I, 106 M PDBu-
stimulated cells in the presence of 10e6 M blebbistatin. G, H, and I are TEM images (scale bar, 100 nm). In G, double black arrowheads denote the tracks composed of bundled actin
ﬁlaments often found in vehicle VSMCs, and single black arrows denote electron-dense parts on the tracks. In H, podosomes were induced by PDBu. White arrows indicate myosin-
heads associated with actin ﬁlaments, feet of podosomes are denoted by black arrowheads, and actin ﬁlaments of legs are denoted by black arrows. In I, podosomes were induced in
the presence of blebbistatin. Note that shorter legs are indicated by black arrows, smaller feet in blebbistatin are indicated by black arrowheads, and myosin assembled areas are
indicated by white arrows. In J, foot size (nm2) was measured, and in K, the length (nm) of legs was measured. In J and K, the black arrow and the gray arrow denote mean values in
the presence and absence of blebbistatin, respectively.
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Fig. 3. Immunoelectron micrographs with TEM. The method was previously described in detail by Tanaka et al (15). Brieﬂy, A7r5 cells were ﬁxed with 1.5% paraformaldehyde, and
treated with 0.5% Triton X-100 in 10% sucrose in 0.1 M cacodylate buffer (pH 7.3) for 10 min at 4 C for pearmeablization to antibodies. They were incubated with BSA in the same
buffer for blocking nonspeciﬁc reactions and were then incubated with primary antibody against MLCK (monoclonal K36 Sigma Aldrich), followed by incubation with the secondary
antibody conjugated to 6-nm gold particles (Jackson Immuno Research). They were processed for TEM observation, as described in Fig. 1C. A, PDBu-stimulated cells in the absence of
blebbistatin; B, PDBu-stimulated cells in the presence of blebbistatin. White arrows, myosin heads showing electron-dense materials of approximately 18 nm; black arrows,
podosome's legs; black arrowheads, podosome's feet. Note that myosin disappeared from the podosome after blebbistatin treatment, but MLCK, as marked by the gold particle of
6 nm, still remained in association with the actin ﬁlaments of podosomes.
H. Tanaka et al. / Journal of Pharmacological Sciences 128 (2015) 78e8282indicating the localization of MLCK was 65.5%. We attributed the
increase to the detachment of myosin-heads from the actin ﬁla-
ments of the podosomes, creating easy access of MLCK to the actin
ﬁlaments. As described in the introductory remarks, MLCK has
actin-binding activity (4, 10). Therefore, we explained that the
actin-binding activity of MLCK has an essential role in podosome
formation. However, we must note that the structure of the
podosomes was reduced in size by the blebbistatin treatment
(compare Fig. 2E with Fig. 2F). A TEM image of a larger podosome
(Fig. 3A) showed that actin-ﬁlaments were associatedwithmyosin-
heads. However, smaller podosomes comprising actin ﬁlaments
were not associated with myosin-heads. Instead, the myosin-heads
were clustered at the areas remote from these podosomes as shown
bywhite arrows in Fig. 3B.We speculated thatmyosin association is
required for mature, larger podosome formation, but not for
smaller podosomes.
There is an additional class of podosome that is constitutionally
expressed on the surface of cells, for example, macrophages (16).
According to ref.16, larger podosomes exist on the leading edge of a
cell and smaller podosomes in the cell interior. The larger podo-
some is a precursor to the smaller successor. PDBu-induced podo-
somes are large (Fig. 2E), and become small (Fig. 2F) through
blebbistatin-treatment. The present study on PDBu-induced
podosomes showed that the association of podosomes with
myosin-heads reduced their size and that the association of MLCK
with the actin-core through the actin-binding domain is required in
the both forms. Therefore, the larger podosome is the precursor of
the smaller podosome, which may be the difference between the
PDBu-induced class and the constitutive class in terms of actin
myosin interaction.
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